211 related articles for article (PubMed ID: 27965983)
1. Xanthine Oxidase Activity in Type 2 Diabetes Mellitus Patients with and without Diabetic Peripheral Neuropathy.
Miric DJ; Kisic BM; Filipovic-Danic S; Grbic R; Dragojevic I; Miric MB; Puhalo-Sladoje D
J Diabetes Res; 2016; 2016():4370490. PubMed ID: 27965983
[TBL] [Abstract][Full Text] [Related]
2. Glycated albumin indicates peripheral diabetic neuropathy.
Wang N; Guo C; Han P; Li T
Acta Diabetol; 2016 Dec; 53(6):973-979. PubMed ID: 27573202
[TBL] [Abstract][Full Text] [Related]
3. Xanthine oxidase and lens oxidative stress markers in diabetic and senile cataract patients.
Miric DJ; Kisic BB; Zoric LD; Mitic RV; Miric BM; Dragojevic IM
J Diabetes Complications; 2013; 27(2):171-6. PubMed ID: 23142692
[TBL] [Abstract][Full Text] [Related]
4. Association between Fluorescent Advanced Glycation End-Products and Vascular Complications in Type 2 Diabetic Patients.
Guerin-Dubourg A; Cournot M; Planesse C; Debussche X; Meilhac O; Rondeau P; Bourdon E
Biomed Res Int; 2017; 2017():7989180. PubMed ID: 29362717
[TBL] [Abstract][Full Text] [Related]
5. [Relationship between serum cystatin-C levels and vibrating perception threshold in patients with
Type 2 diabetes mellitus].
Yan P; Zhang Z; Xu Y; Wan Q; Ma H; He J
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2016 Jan; 41(1):58-64. PubMed ID: 26819426
[TBL] [Abstract][Full Text] [Related]
6. Clinical Features and Microvascular Complications Risk Factors of Early-onset Type 2 Diabetes Mellitus.
Huang JX; Liao YF; Li YM
Curr Med Sci; 2019 Oct; 39(5):754-758. PubMed ID: 31612393
[TBL] [Abstract][Full Text] [Related]
7. Glycated albumin and its variability as an indicator of cardiovascular autonomic neuropathy development in type 2 diabetic patients.
Jun JE; Lee SE; Lee YB; Ahn JY; Kim G; Jin SM; Hur KY; Lee MK; Kim JH
Cardiovasc Diabetol; 2017 Oct; 16(1):127. PubMed ID: 29017498
[TBL] [Abstract][Full Text] [Related]
8. Glycated albumin and ratio of glycated albumin to glycated hemoglobin are good indicators of diabetic nephropathy in type 2 diabetes mellitus.
Wang N; Xu Z; Han P; Li T
Diabetes Metab Res Rev; 2017 Feb; 33(2):. PubMed ID: 27537245
[TBL] [Abstract][Full Text] [Related]
9. Diabetic peripheral neuropathy: age-stratified glycemic control.
Wang CS; Pai YW; Lin CH; Lee IT; Chen HH; Chang MH
Front Endocrinol (Lausanne); 2024; 15():1377923. PubMed ID: 38694945
[TBL] [Abstract][Full Text] [Related]
10. Association between serum asprosin and diabetic peripheral neuropathy in patients with type 2 diabetes mellitus in the community.
Xu LX; Yin JH; Liang D; Li P; Xu MG; Shi GL; Wang Y; Yang J
Eur Rev Med Pharmacol Sci; 2023 Aug; 27(16):7569-7575. PubMed ID: 37667933
[TBL] [Abstract][Full Text] [Related]
11. Factors associated with peripheral neuropathy in type 2 diabetes: Subclinical versus confirmed neuropathy.
Unmar Y; Zafar MI; Gao F
J Huazhong Univ Sci Technolog Med Sci; 2017 Jun; 37(3):337-342. PubMed ID: 28585130
[TBL] [Abstract][Full Text] [Related]
12. TOTAL BODY ADIPOSITY, TRIGLYCERIDES, AND LEG FAT ARE INDEPENDENT RISK FACTORS FOR DIABETIC PERIPHERAL NEUROPATHY IN CHINESE PATIENTS WITH TYPE 2 DIABETES MELLITUS.
Zhen Q; Yao N; Chen X; Zhang X; Wang Z; Ge Q
Endocr Pract; 2019 Mar; 25(3):270-278. PubMed ID: 30913011
[TBL] [Abstract][Full Text] [Related]
13. The association of serum glycated albumin with the prevalence of diabetic retinopathy in Korean patients with type 2 diabetes mellitus.
Jeon WS; Park SE; Rhee EJ; Lee WY; Oh KW; Park SW; Park CY
Diabetes Res Clin Pract; 2016 Jun; 116():46-53. PubMed ID: 27321316
[TBL] [Abstract][Full Text] [Related]
14. Skin autofluorescence is associated with severity of vascular complications in Japanese patients with Type 2 diabetes.
Tanaka K; Tani Y; Asai J; Nemoto F; Kusano Y; Suzuki H; Hayashi Y; Asahi K; Nakayama M; Miyata T; Watanabe T
Diabet Med; 2012 Apr; 29(4):492-500. PubMed ID: 21916970
[TBL] [Abstract][Full Text] [Related]
15. Prevalence and risk factors of diabetic peripheral neuropathy: A population-based cross-sectional study in China.
Wang W; Ji Q; Ran X; Li C; Kuang H; Yu X; Fang H; Yang J; Liu J; Xue Y; Feng B; Lei M; Zhu D
Diabetes Metab Res Rev; 2023 Nov; 39(8):e3702. PubMed ID: 37490047
[TBL] [Abstract][Full Text] [Related]
16. Glycated albumin versus glycated hemoglobin as glycemic indicator in hemodialysis patients with diabetes mellitus: variables that influence.
Sany D; Elshahawy Y; Anwar W
Saudi J Kidney Dis Transpl; 2013 Mar; 24(2):260-73. PubMed ID: 23538348
[TBL] [Abstract][Full Text] [Related]
17. Genomic DNA Methylation in Diabetic Chronic Complications in Patients With Type 2 Diabetes Mellitus.
Wang X; Yang W; Zhu Y; Zhang S; Jiang M; Hu J; Zhang HH
Front Endocrinol (Lausanne); 2022; 13():896511. PubMed ID: 35846305
[TBL] [Abstract][Full Text] [Related]
18. Assessment of Peripheral Neuropathy Using Measurement of the Current Perception Threshold with the Neurometer® in patients with type 1 diabetes mellitus.
Lv SL; Fang C; Hu J; Huang Y; Yang B; Zou R; Wang FY; Zhao HQ
Diabetes Res Clin Pract; 2015 Jul; 109(1):130-4. PubMed ID: 25981398
[TBL] [Abstract][Full Text] [Related]
19. The Association between Genomic DNA Methylation and Diabetic Peripheral Neuropathy in Patients with Type 2 Diabetes Mellitus.
Zhang HH; Han X; Wang M; Hu Q; Li S; Wang M; Hu J
J Diabetes Res; 2019; 2019():2494057. PubMed ID: 31781662
[TBL] [Abstract][Full Text] [Related]
20. The association between pulse wave velocity and peripheral neuropathy in patients with type 2 diabetes mellitus.
Tentolouris A; Eleftheriadou I; Grigoropoulou P; Kokkinos A; Siasos G; Ntanasis-Stathopoulos I; Tentolouris N
J Diabetes Complications; 2017 Nov; 31(11):1624-1629. PubMed ID: 28893495
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]